Loading viewer...
annual_report
Format: PDF annual_report
Alzamend Neuro, Inc. (NASDAQ: ALZN) is a biotech company filing its annual report for fiscal year ended April 30, 2023. The company operates from Atlanta, Georgia and is classified as a non-accelerated filer, smaller reporting company, and emerging growth company.
annual_report
Konami Group Corporation
annual_report
105 Pages
annual_report
McKesson
annual_report
Resideo Technologies
Agilent Technologies 2016 Annual Report
annual_reportannual_report
128 Pages
Agilent Technologies